We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+8.99%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$21.9B
AUM Growth
+$21.9B
(+100,205%)
Cap. Flow
-$417M
Cap. Flow
% of AUM
-1.9%
Top 10 Holdings %
Top 10 Hldgs %
13.08%
Holding
3,337
New
135
Increased
1,103
Reduced
1,007
Closed
163
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$89.3M |
| 2 |
Keysight
KEYS
|
+$86M |
| 3 |
Nike
NKE
|
+$78.3M |
| 4 |
Amphenol
APH
|
+$76.5M |
| 5 |
Comcast
CMCSA
|
+$72.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Celanese
CE
|
+$108M |
| 2 |
Monster Beverage
MNST
|
+$97.8M |
| 3 |
Starbucks
SBUX
|
+$79.7M |
| 4 |
Texas Instruments
TXN
|
+$67.3M |
| 5 |
Centene
CNC
|
+$64.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.83% |
| 2 | Financials | 13.42% |
| 3 | Healthcare | 13.25% |
| 4 | Industrials | 9.77% |
| 5 | Consumer Discretionary | 7.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
Invesco Dorsey Wright Industrials Momentum ETF
PRN
$405M
| $183K | ﹤0.01% |
2,686
| – | – |
|
1052
SolarEdge
SEDG
$2.44B
| $183K | ﹤0.01% |
1,935
-160
| -8% | -$13.7K |
|
1053
Ball Corp
BALL
$17.8B
| $182K | ﹤0.01% |
2,827
-240
| -8% | -$16.3K |
|
1054
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.9B
| $182K | ﹤0.01% |
4,850
| – | – |
|
1055
Booz Allen Hamilton
BAH
$8.78B
| $181K | ﹤0.01% |
2,562
-43
| -2% | -$3.06K |
|
1056
NiSource
NI
$21.9B
| $181K | ﹤0.01% |
6,557
-5,280
| -45% | -$145K |
|
1057
Wyndham Hotels & Resorts
WH
$5.62B
| $181K | ﹤0.01% |
2,890
| – | – |
|
|
NBL
1058
DELISTED
Noble Energy, Inc.
NBL
| $181K | ﹤0.01% |
7,343
-883
| -11% | -$18.8K |
|
1059
Hexcel
HXL
$8.3B
| $180K | ﹤0.01% |
2,467
+70
| +3% | +$5.38K |
|
1060
Omnicell
OMCL
$1.96B
| $180K | ﹤0.01% |
2,208
-1,378
| -38% | -$106K |
|
1061
Pinterest
PINS
$13.6B
| $179K | ﹤0.01% |
9,683
+6,908
| +249% | +$149K |
|
|
TUP
1062
DELISTED
Tupperware Brands Corporation
TUP
| $178K | ﹤0.01% |
20,845
-61
| -0.3% | -$665 |
|
|
MZTI
1063
The Marzetti Company
MZTI
$3.02B
| $177K | ﹤0.01% |
1,108
-175
| -14% | -$26.3K |
|
1064
Invesco Dorsey Wright Healthcare Momentum ETF
PTH
$220M
| $176K | ﹤0.01% |
5,541
| – | – |
|
1065
ProShares Short S&P500
SH
$914M
| $176K | ﹤0.01% |
1,848
| – | – |
|
|
ANSS
1066
DELISTED
Ansys
ANSS
| $175K | ﹤0.01% |
680
-5
| -0.7% | -$1.18K |
|
1067
Descartes Systems
DSGX
$6.48B
| $175K | ﹤0.01% |
4,110
+1,150
| +39% | +$46.9K |
|
1068
Watsco Inc
WSO
$15.1B
| $175K | ﹤0.01% |
972
+17
| +2% | +$2.99K |
|
|
SCM
1069
DELISTED
SWISSCOM AG ADS(RP 1/10 REG SH
SCM
| $174K | ﹤0.01% |
3,318
-27,968
| -89% | -$1.47M |
|
1070
Axos Financial
AX
$5.64B
| $173K | ﹤0.01% |
5,737
+134
| +2% | +$3.92K |
|
1071
Freeport-McMoran
FCX
$88.6B
| $170K | ﹤0.01% |
13,008
-138
| -1% | -$1.51K |
|
1072
Qualys
QLYS
$4.78B
| $170K | ﹤0.01% |
2,049
+1,810
| +757% | +$150K |
|
|
WWE
1073
DELISTED
World Wrestling Entertainment
WWE
| $170K | ﹤0.01% |
2,629
+2,003
| +320% | +$127K |
|
1074
Applied Industrial Technologies
AIT
$12.9B
| $169K | ﹤0.01% |
2,549
+153
| +6% | +$9.38K |
|
1075
VanEck Agribusiness ETF
MOO
$998M
| $169K | ﹤0.01% |
2,480
-33
| -1% | -$2.2K |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q4 2019 Portfolio in Review
As of Q4 2019, Glenmede Trust held 3,337 positions worth $21.9B, up 100,205% from $21.9M the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Glenmede Trust's Q4 2019 filing shows 135 new, 1,103 increased, 1,007 reduced and 163 closed positions. Its largest new stake was Callon Petroleum Company: 285,674 shares worth $13.8M. The largest sale was Celanese, an estimated $108M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- Glenmede Trust's largest Q4 2019 buy was Callon Petroleum Company: 285,674 shares worth $13.8M.
- Glenmede Trust added most to Bristol-Myers Squibb in Q4 2019, an estimated $89.3M increase.
- Glenmede Trust's biggest Q4 2019 reduction was Celanese, cutting an estimated $108M.
- Glenmede Trust fully exited Celgene Corp in Q4 2019, selling an estimated $122K.
- Glenmede Trust's ten largest holdings make up 13% of its $21.9B portfolio in Q4 2019.
- Glenmede Trust opened 135 new positions and closed 163 in Q4 2019.
- Glenmede Trust's portfolio value rose 100,205% quarter-over-quarter to $21.9B.
Based on Glenmede Trust's 13F filing for Q4 2019, filed 12 Feb 2020.